More than 3 million Americans and 24 million people worldwide suffer from schizophrenia. Even with the amazing drugs available to them, they still suffer from symptoms as well as a wide range of side effects from the drugs used to treat them. But there's a new hope. Brilaroxazine, a new drug in Phase 3 clinical trials, may finally offer be an effective, life-improving mental health treatment with significantly reduced side effects.
